Hodgkin-lymphoma adolescens korban. Hol érdemes kezelni: Felnott- vagy gyermekintézményben?

Translated title of the contribution: Hodgkin's lymphoma in adolescents

Judit Müller, Zsuzsanna Molnár, Árpád Illés, Monika Csóka, Zsuzsanna Jakab, Beáta Deák, Tamás Schneider, Erika Várady, András Rosta, Zsófia Simon, Katalin Keresztes, Lajos Gergely, Gábor Kovács

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Adolescent patients with Hodgkin's lymphoma (HL) are treated either in pediatric, or in adult oncological wards. Aim: The aim of our work was to compare the treatment modalities and the survival rates in adolescents with HL treated in adult (A) or pediatric (P) institutes. Methods: From January 1990 to December 2004, 138 patients (14-21 years) with HL were treated in two adult institutes (A) and 107 in the 10 centres of the Hungarian Pediatric Oncology Network (P). Results: Male:female ratio was 1:1.15 (A) and 1:1.38 (P). The mean age was 18.6 (A) and 15.7 (P) years. There was no difference between the distribution of the stages in the two patient groups. The distribution of histological subtypes (A and P): nodular sclerosing 47% and 59%, mixed ceflularity 45% and 25%, lymphocyte rich 1.5% and 10%, lymphocyte depleted 4% and 1%, nodular lymphocyte predominant 1.5% and 3% and unknown 1% and 2%. The majority of the patients were treated with ABVD (A) and OPPA/OEPA±COPP (P). One hundred and fifteen (A) and 97 (P) adolescents received irradiation therapy. 80% (A) and 91% (A) of the patients got radiotherapy. In group A 14%, in group P 13% of the patients had relapse. In group A 16 patients died and in group P 7. There was no significant difference in the overall survival (OS) rates at 5 and 10 years in the two patient groups. The event-free survival (EFS) was 76.5±4% and 72.5±4% at 5 and 10 years in group A, and 85.3±4% at both times in group P (p = 0.0452). Conclusion: Survival rates in HL are quite high, 80-90% of the patients can be cured. Event-free survival was higher in pediatric than in adult institutes. In case of patients younger than 18 years, the survival rates were much better in pediatric institutes, so these patients should be treated in pediatric institutes or with protocols used by the pediatricians.

Translated title of the contributionHodgkin's lymphoma in adolescents
Original languageHungarian
Pages (from-to)2221-2227
Number of pages7
JournalOrvosi hetilap
Volume149
Issue number47
DOIs
Publication statusPublished - Nov 23 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hodgkin's lymphoma in adolescents: Felnott- vagy gyermekintézményben?'. Together they form a unique fingerprint.

  • Cite this

    Müller, J., Molnár, Z., Illés, Á., Csóka, M., Jakab, Z., Deák, B., Schneider, T., Várady, E., Rosta, A., Simon, Z., Keresztes, K., Gergely, L., & Kovács, G. (2008). Hodgkin-lymphoma adolescens korban. Hol érdemes kezelni: Felnott- vagy gyermekintézményben? Orvosi hetilap, 149(47), 2221-2227. https://doi.org/10.1556/OH.2008.28447